Novo Nordisk As Stock Price History

NVO Stock  USD 90.95  0.36  0.40%   
If you're considering investing in Novo Stock, it is important to understand the factors that can impact its price. As of today, the current price of Novo Nordisk stands at 90.95, as last reported on the 25th of February, with the highest price reaching 93.80 and the lowest price hitting 89.00 during the day. Novo Nordisk AS has Sharpe Ratio of -0.0667, which conveys that the firm had a -0.0667 % return per unit of risk over the last 3 months. Novo Nordisk exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novo Nordisk's Standard Deviation of 3.38, risk adjusted performance of (0.04), and Mean Deviation of 2.09 to check out the risk estimate we provide.
  
Novo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0667

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNVO

Estimated Market Risk

 3.38
  actual daily
30
70% of assets are more volatile

Expected Return

 -0.23
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Novo Nordisk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novo Nordisk by adding Novo Nordisk to a well-diversified portfolio.

Novo Nordisk Stock Price History Chart

There are several ways to analyze Novo Stock price data. The simplest method is using a basic Novo candlestick price chart, which shows Novo Nordisk price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 11, 2024111.69
Lowest PriceFebruary 14, 202577.87

Novo Nordisk February 25, 2025 Stock Price Synopsis

Various analyses of Novo Nordisk's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Novo Stock. It can be used to describe the percentage change in the price of Novo Nordisk from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Novo Stock.
Novo Nordisk Price Rate Of Daily Change 1.00 
Novo Nordisk Price Action Indicator(0.27)
Novo Nordisk Price Daily Balance Of Power 0.07 
Novo Nordisk Accumulation Distribution 569,051 

Novo Nordisk February 25, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Novo Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Novo Nordisk intraday prices and daily technical indicators to check the level of noise trading in Novo Stock and then apply it to test your longer-term investment strategies against Novo.

Novo Stock Price History Data

The price series of Novo Nordisk for the period between Wed, Nov 27, 2024 and Tue, Feb 25, 2025 has a statistical range of 33.82 with a coefficient of variation of 12.02. The daily prices for the period are spread out with arithmetic mean of 91.03. The median price for the last 90 days is 86.26. The company underwent 2:1 stock split on 20th of September 2023. Novo Nordisk AS issued dividends to stockholders on 2025-03-31.
OpenHighLowCloseVolume
02/25/2025 92.28  93.80  89.00  90.95  11,120,204 
02/24/2025 88.86  91.12  88.12  90.59  10,476,300 
02/21/2025 88.39  89.23  85.74  88.08  15,044,825 
02/20/2025 82.93  84.00  82.71  83.74  5,015,200 
02/19/2025 82.94  83.63  82.56  83.40  5,707,842 
02/18/2025 82.10  82.68  81.06  82.33  8,404,893 
02/14/2025 78.58  79.07  77.82  77.87  9,860,416 
02/13/2025 79.54  80.14  78.70  78.83  10,359,994 
02/12/2025 81.02  82.36  80.53  81.79  5,743,394 
02/11/2025 83.51  84.25  82.87  83.74  4,614,338 
02/10/2025 85.70  85.90  83.65  83.91  9,542,066 
02/07/2025 88.69  88.77  86.14  86.42  8,698,100 
02/06/2025 86.72  88.94  86.67  87.17  10,154,231 
02/05/2025 86.43  87.42  85.13  85.73  13,238,127 
02/04/2025 81.62  83.44  81.27  82.62  9,880,700 
02/03/2025 82.13  83.38  82.07  82.65  5,460,100 
01/31/2025 84.87  85.44  84.29  84.45  6,546,200 
01/30/2025 84.60  86.47  83.94  85.34  5,798,800 
01/29/2025 85.62  85.67  83.90  84.03  6,843,900 
01/28/2025 86.07  86.86  84.60  85.19  9,534,300 
01/27/2025 85.74  88.46  85.34  87.51  10,864,900 
01/24/2025 89.97  89.97  86.57  87.97  27,095,400 
01/23/2025 81.33  81.72  80.33  81.10  6,765,800 
01/22/2025 81.73  81.80  80.43  80.57  5,910,400 
01/21/2025 79.68  81.11  79.32  81.03  8,094,300 
01/17/2025 79.94  80.88  78.17  78.69  21,265,300 
01/16/2025 82.74  83.99  82.19  83.07  6,322,400 
01/15/2025 83.36  83.82  82.71  82.92  9,021,500 
01/14/2025 82.92  83.68  80.05  81.18  13,694,900 
01/13/2025 84.42  84.72  83.69  84.62  7,412,400 
01/10/2025 87.22  87.28  85.84  86.26  6,774,700 
01/08/2025 85.51  85.80  84.68  85.64  9,196,400 
01/07/2025 84.10  84.81  82.64  83.34  9,567,900 
01/06/2025 86.11  86.34  84.80  85.03  10,695,700 
01/03/2025 87.49  88.19  87.34  87.65  3,769,000 
01/02/2025 87.91  88.51  87.19  87.52  4,570,300 
12/31/2024 85.42  86.05  85.00  86.02  4,202,400 
12/30/2024 86.97  87.01  85.66  85.73  6,110,000 
12/27/2024 87.73  88.77  87.02  87.37  6,066,000 
12/26/2024 87.17  88.06  86.87  87.65  6,289,300 
12/24/2024 88.90  88.98  87.07  87.37  4,774,900 
12/23/2024 88.87  89.10  85.99  88.71  18,997,900 
12/20/2024 82.72  86.53  81.50  85.00  53,762,400 
12/19/2024 104.27  104.75  102.74  103.44  5,344,400 
12/18/2024 108.39  109.04  105.48  105.96  3,760,900 
12/17/2024 107.75  108.99  107.73  108.01  5,415,500 
12/16/2024 109.29  109.88  107.87  108.05  5,346,900 
12/13/2024 107.04  107.61  104.14  106.95  6,250,400 
12/12/2024 110.88  111.17  108.41  108.61  3,650,800 
12/11/2024 110.45  112.52  110.02  111.69  6,545,700 
12/10/2024 111.55  111.55  108.70  109.19  4,621,700 
12/09/2024 111.72  111.99  110.30  111.08  4,908,900 
12/06/2024 109.93  111.31  109.75  110.77  6,045,700 
12/05/2024 108.62  109.32  108.23  108.82  3,914,400 
12/04/2024 110.22  110.52  108.96  108.97  4,485,600 
12/03/2024 110.78  110.88  109.05  109.20  4,828,700 
12/02/2024 108.93  109.14  108.15  108.67  4,948,300 
11/29/2024 105.43  107.40  105.35  106.80  2,775,100 
11/27/2024 105.79  106.13  104.96  106.13  3,990,600 
11/26/2024 106.67  107.70  105.63  106.13  6,761,400 
11/25/2024 105.31  105.92  104.00  104.56  4,294,600 

About Novo Nordisk Stock history

Novo Nordisk investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novo Nordisk AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novo Nordisk stock prices may prove useful in developing a viable investing in Novo Nordisk
Novo Nordisk AS, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Novo Nordisk is traded on New York Stock Exchange in the United States.

Novo Nordisk Stock Technical Analysis

Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Novo Nordisk technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Novo Nordisk trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Fundamental Analysis Now

   

Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module

Novo Nordisk Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Novo Nordisk's price direction in advance. Along with the technical and fundamental analysis of Novo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Nordisk. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Nordisk listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Novo Nordisk AS is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Nordisk's value that differs from its market value or its book value, called intrinsic value, which is Novo Nordisk's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Nordisk's market value can be influenced by many factors that don't directly affect Novo Nordisk's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Nordisk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Nordisk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Nordisk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.